Bayer turns digital health programs into joint initiative

German life sciences group Bayer (BAYN: DE) has combined its digital health programs to form the G4 Partnerships initiative.

Instead of one-off start-up programs, the company is now focusing on collaborating in specific digital health focus areas such as digital therapeutics, artificial intelligence for drug discovery, and patient engagement platforms.

Eugene Borukhovich, global head of digital health at Bayer, said: “The digital health ecosystem has matured over the years and there are some very well-developed start-ups across the value chain. We wanted to simplify the process for entrepreneurs to work with Bayer and scale innovative solutions together, faster. That’s why it’s time to take the way we collaborate to the next level.”